IDDEA-HF
A Phase 2 Randomized, Double-Blinded, Placebo-Controlled Study to Evaluate the Cardiac and Renal Effects of Short Term Treatment with Elamipretide in Patients Hospitalized with Peripheral Oedema due to Heart Failure
- Stadium
- klaar
- Middel
- elamipretide
- Populatie
- Hartfalen
- Fase
- II
- First Patient In
- 1 september 2016
- Last Patient In
- 15 november 2017
- Last Patient Last Visit
- -
National Lead
prof. dr. A. Voors
Cardioloog
Studiedirecteur
